Emergence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) infection in Western Australia

Murray, Ronan J; Sieunarine, Kishore; Ward, Peter B; Pearman, John W

doi:10.5694/j.1326-5377.2004.tb06246.x

Topics

Infectious diseases

Ronan J Murray,* Kishore Sieunarine,† Peter B Ward,‡ John W Pearman§

2 Royal Perth Hospital, Perth, WA
3 Department of Microbiology, Austin Repatriation Medical Centre, Heidelberg, VIC.

Correspondence: ronan.murray@health.wa.gov.au

Acknowledgements:

We thank Geoff Coombs, Frances O’Brien, Mary Malkowski and Julie Pearson, from the Department of Microbiology and Infectious Diseases and the Gram Positive Typing and Research Unit, Royal Perth Hospital and Curtin University of Technology, for performing MRSA typing of the isolates.

1. Ward PB, Johnson PD, Grabsch EA, et al. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust 2001; 175: 480-483. <MJA full text>
2. Gosbell IB, Mitchell DH, Ziochos H, Ward PB. Emergence of hetero-vancomycin-intermediate Staphylococcus aureus (hVISA) in Sydney. Med J Aust 2003; 178: 354. <MJA full text>
3. Riley TV, Pearman JW, Rouse IL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1995; 163: 412-414.
4. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40: 4289-4294.

Online responses are no longer available. Please refer to our instructions for authors page for more information.